QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer
26.10.2023 - Partnership covers development of lab-developed and distributable kit-based companion diagnostic testsCombined strengths in assay development, clinical testing, and regulatory approvals offers pharma partners comprehensive global companion ... Seite 1